Literature DB >> 14737005

Evaluating the human relevance of chemically induced animal tumors.

Samuel M Cohen1, James Klaunig, M Elizabeth Meek, Richard N Hill, Timothy Pastoor, Lois Lehman-McKeeman, John Bucher, David G Longfellow, Jennifer Seed, Vicki Dellarco, Penelope Fenner-Crisp, Dorothy Patton.   

Abstract

Defining the mode(s) of action by which chemicals induce tumors in laboratory animals has become a key to judgments about the relevance of such tumor data for human risk assessment. Frameworks for analyzing mode of action information appear in recent U.S. EPA and IPCS publications relating to cancer risk assessment. This FORUM paper emphasizes that mode of action analytical frameworks depend on both qualitative and quantitative evaluations of relevant data and information: (1) presenting key events in the animal mode of action, (2) developing a "concordance" table for side-by-side comparison of key events as defined in animal studies with comparable information from human systems, and (3) using data and information from mode of action analyses, as well as information on relative sensitivity and exposure, to make weight-of-evidence judgments about the relevance of animal tumors for human cancer assessments. The paper features a systematic analysis for using mode of action information from animal and human studies, based in part on case examples involving environmental chemicals and pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14737005     DOI: 10.1093/toxsci/kfh073

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Identifying an indoor air exposure limit for formaldehyde considering both irritation and cancer hazards.

Authors:  Robert Golden
Journal:  Crit Rev Toxicol       Date:  2011-06-02       Impact factor: 5.635

Review 2.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

Review 3.  Case examples of an evaluation of the human relevance of the pyrethroids/pyrethrins-induced liver tumours in rodents based on the mode of action.

Authors:  Tomoya Yamada
Journal:  Toxicol Res (Camb)       Date:  2018-01-16       Impact factor: 3.524

Review 4.  Goodbye to the bioassay.

Authors:  Jay I Goodman
Journal:  Toxicol Res (Camb)       Date:  2018-02-06       Impact factor: 3.524

Review 5.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

6.  Chemical carcinogenesis - mode of action to inform quantitative human risk.

Authors:  João Lauro V de Camargo
Journal:  BMC Proc       Date:  2013-04-04

7.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

8.  Successful drug development despite adverse preclinical findings part 2: examples.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; Makoto Hayashi; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

9.  PET/CT imaging of c-Myc transgenic mice identifies the genotoxic N-nitroso-diethylamine as carcinogen in a short-term cancer bioassay.

Authors:  Katja Hueper; Mahmoud Elalfy; Florian Laenger; Roman Halter; Thomas Rodt; Michael Galanski; Juergen Borlak
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

Review 10.  Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs.

Authors:  Timothy J Shafer; Douglas A Meyer; Kevin M Crofton
Journal:  Environ Health Perspect       Date:  2005-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.